Comparison of Clinical Outcomes Following Gefitinib and Erlotinib Treatment in Non–Small-Cell Lung Cancer Patients Harboring an Epidermal Growth Factor Receptor Mutation in Either Exon 19 or 21

DOI Web Site Web Site 1 Citations

Journal

Citations (1)*help

See more

Keywords

Report a problem

Back to top